期刊
INTERNATIONAL JOURNAL OF CANCER
卷 143, 期 1, 页码 8-15出版社
WILEY
DOI: 10.1002/ijc.31200
关键词
immunotherapy; ovarian cancer; pathology; neoadjuvant chemotherapy; TILs
类别
资金
- Diplome Universitaire Europeen de Recherche Translationnelle Et Clinique en Cancerologie
- Institut National du Cancer
Over the last decade, increasing evidence highlights the role of the host immune system in the control of tumor growth and the prognostic implications of tumor infiltrating lymphocytes (TILs) in ovarian cancer. Most data support a better prognosis with accumulation of CD3+ and CD8+TILs and a poor outcome associated with increased regulatory T cells. However, only a small number of studies have focused on the effect of neoadjuvant chemotherapy (NACT) on the tumor immune microenvironment. This review will provide an update on the prognostic value of TIL subpopulations at diagnosis and a comprehensive overview of the recent studies evaluating the impact of neoadjuvant chemotherapy on TILs and their relationship to clinical outcome in advanced ovarian cancer. This information could help in future investigations of immunotherapy as maintenance following primary treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据